StonvexLoading…
StonvexStonvexStonvexCore line items from GLIBA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $272.95M | $256.00M | $1.05B | $784.00M | $527.00M |
Operating Income | Not available | $30.00M | $-347.00M | $-379.00M | $109.00M |
Net Income | Not available | $18.00M | $-309.00M | $-325.00M | $62.00M |
EPS (Diluted) | $1.18 | $0.45 | $-9.97 | $-11.21 | Not available |
Total Assets | Not available | $3.25B | $3.23B | $3.01B | $3.35B |
Total Liabilities | Not available | $1.52B | $1.53B | $1.62B | $1.86B |
Cash & Equivalents | Not available | $435.00M | $416.00M | $124.00M | $104.00M |
Free Cash Flow OCF − CapEx | Not available | $22.00M | $122.00M | $128.00M | $107.00M |
Shares Outstanding | Not available | 40.00M | 31.00M | 29.00M | Not available |